Avidity Biosciences, Inc. 10-K Cybersecurity GRC - 2024-02-28

Page last updated on July 16, 2024

Avidity Biosciences, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-02-28 16:17:47 EST.

Filings

10-K filed on 2024-02-28

Avidity Biosciences, Inc. filed a 10-K at 2024-02-28 16:17:47 EST
Accession Number: 0001599901-24-000025

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. Cybersecurity We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information. Our cybersecurity risk management program includes a cybersecurity incident response plan. Our cybersecurity risk management program is integrated into our overall enterprise risk management program, and shares common methodologies, reporting channels and governance processes that apply across the enterprise risk management program to other legal, compliance, strategic, operational and financial risk areas. Our cybersecurity risk management program includes: - annual external and internal penetration tests to help identify material cybersecurity risks to our critical systems, information and our broader enterprise IT environment; - a security team that includes internal IT and data privacy personnel and external managed services partners, principally responsible for managing (i) our cybersecurity risk assessment processes, (ii) our security controls and (iii) our response to cybersecurity incidents; - use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security controls, including: - annual external and internal penetration tests; - 24-hour monitoring of our networks and cloud resources to help detect, respond to and recover from cyber-attacks; - IT managed services that includes help desk support and managed infrastructure (networks and servers support); and - a ransomware defense plan. - cybersecurity awareness training for our employees, incident response personnel and senior management; - a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents; and - third-party risk management and reporting process for service providers, suppliers and vendors. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. In the event we experience a cybersecurity incident we consider to be material, we will disclose such incident consistent with the requirements of Item 1.05 of Form 8-K. Cybersecurity Governance Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to the audit committee of the board of directors, or the audit committee, oversight of cybersecurity and other information technology risks. The audit committee oversees management’s implementation of our cybersecurity risk management program. The audit committee receives periodic reports from management on our cybersecurity risks. In addition, management alerts the audit committee of any material cybersecurity incidents. The audit committee reports to the full board of directors regarding its activities, including those related to cybersecurity. Board members receive presentations on cybersecurity topics from management and have available to them external resources related to cybersecurity as part of the board of directors’ continuing education on topics that impact companies similar to ours. Our cybersecurity function is overseen by Michael MacLean, Chief Financial and Chief Business Officer, who leads a team that is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management team supervises efforts to prevent, detect, mitigate and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.


Company Information

NameAvidity Biosciences, Inc.
CIK0001599901
SIC DescriptionPharmaceutical Preparations
TickerRNA - Nasdaq
Website
CategoryLarge accelerated filer
Fiscal Year EndDecember 30